Antibodies against PCSK9—a new era of therapy

被引:8
|
作者
Alexandra King
机构
关键词
D O I
10.1038/nrcardio.2012.166
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 1
相关论文
共 50 条
  • [1] PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid–Based Therapy Era
    Ioanna Gouni-Berthold
    Jonas Schwarz
    Heiner K. Berthold
    Current Atherosclerosis Reports, 2022, 24 : 779 - 790
  • [2] PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid-Based Therapy Era
    Gouni-Berthold, Ioanna
    Schwarz, Jonas
    Berthold, Heiner K.
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (10) : 779 - 790
  • [3] PCSK9 inhibitors: A new era in stroke prevention?
    Castilla-Guerra, Luis
    Fernandez-Moreno, M. C.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E44 - E44
  • [4] Monoclonal antibodies against PCSK9: from bench to clinic
    Guijarro Herraiz, Carlos
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 : 14 - 21
  • [5] BINDING OF PCSK9 TO CIRCULATING LDL: EFFECT OF PCSK9 MONOCLONAL ANTIBODIES ON THE LDL-BOUND PCSK9?
    De Stefano, D.
    Baragetti, A.
    Baragetti, A.
    Macri, N.
    Tavori, H.
    Fazio, S.
    Catapano, A. L.
    ATHEROSCLEROSIS, 2018, 275 : E101 - E101
  • [6] PCSK9 monoclonal antibodies: An overview
    Kaddoura, Rasha
    Orabi, Bassant
    Salam, Amar M.
    HEART VIEWS, 2020, 21 (02): : 97 - 103
  • [7] PCSK9 Antibodies for the Treatment of Hypercholesterolemia
    Gouni-Berthold, Ioanna
    Berthold, Heiner K.
    NUTRIENTS, 2014, 6 (12): : 5517 - 5533
  • [8] Are antibodies against PCSK9 the statins of the 21st century?
    Tziomalos, Konstantinos
    Athyros, Vasilios G.
    CLINICAL LIPIDOLOGY, 2014, 9 (02) : 141 - 144
  • [9] Cholesterol Management in the Era of PCSK9 Inhibitors
    Svatikova, Anna
    Kopecky, Stephen L.
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (09)
  • [10] Cholesterol Management in the Era of PCSK9 Inhibitors
    Anna Svatikova
    Stephen L. Kopecky
    Current Cardiology Reports, 2017, 19